RxDoctor Payments Data

Graham Calvert, MD

Orthopaedic Surgery of the Spine · Jackson, MSNPI 1861695264

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.8%), food and beverage and royalties or licence payments — rather than concentrated in one kind of arrangement. Zavation Medical Products, LLC accounts for 69.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $7,679 and has fallen 57.0% since, to $3,302 in 2025.

$22,610in general payments, 2019–2025

Across 99 payments — averaging $228.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zavation Medical Products, LLC$16K
  • Abbott$5K
  • CTL Medical Corporation$1K
  • Boston Scientific$265
  • Zynex Medical, Inc.$235
  • Globus Medical$212
  • plus $307 from 6 others

What the payments were for

  • Royalty or licence$3,29615%
  • Consulting fees$11,25050%
  • Travel & lodging$1,2165%
  • Food & beverage$5,83226%
  • Education$1,0154%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopaedic surgery of the spine providers in Mississippito place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$298,749
Medicare patients
250
Services billed
1,137

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclobenzaprine Hcl141$1,416
Mupirocin132$878
Gabapentin108$685
Methylprednisolone109$597
Diclofenac Sodium49$456
Meloxicam61$237
Celecoxib14$187

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →